Skip to content
Screener

Sanara MedTech Inc. SMTI Q2 2026 earnings

Reported August 11, 2026 · After market close

Revenue$28.1MMiss by $813.2K
EPS-$0.05Miss by $0.03
Revenue estimate$29.0M
EPS estimate-$0.03

Next report

Nov 11, 2026 (in a month)
Revenue estimate$29.7M
EPS estimate$0.06

Financials

Q2 2026

Income statement

See full
Revenue$28.1M+9.0%
Gross profit$26.2M+9.6%
Operating income$1.8M-28.4%
Net income-$452.9K+77.5%
EPS (diluted)-$0.05+78.3%

Balance sheet

See full
Cash & equivalents$15.4M-9.1%
Total debt$48.5M+6.8%
Total equity$7.9M-77.6%
Total assets$69.1M-30.0%

Cash flow

See full
CapEx$5.3K-99.7%

Valuation & ratios

Valuation

as of 10/02/26
See full
Market cap$320.48M+16.6%
Enterprise value$353.59M+15.0%
P/S2.9×+0.2×

Profitability

See full
Gross margin93%+1.3pp
Operating margin7.7%+1.1pp
Net margin-29.2%-63.4pp

Returns & leverage

See full
Return on equity-147.7%-187pp
Debt / equity6.1×+4.8×
Current ratio2.6×+0.3×

Segments

By product

See full
Soft Tissue Repair Products$25.2M+11.4%
Bone Fusion Products$2.9M-7.9%

FAQ

When did Sanara MedTech Inc. report Q2 2026 earnings?
Sanara MedTech Inc. (SMTI) reported Q2 2026 earnings on August 11, 2026 after market close.
What were Sanara MedTech Inc.'s Q2 2026 revenue and EPS?
Sanara MedTech Inc. reported revenue of $28.1M and eps of $-0.05 for Q2 2026.
Did Sanara MedTech Inc. beat estimates in Q2 2026?
Revenue missed the consensus estimate of $29.0M by $813.2K. EPS missed the consensus estimate of $-0.03 by $0.03.
How did Sanara MedTech Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.9% from $25.8M a year earlier and eps grew 78.3% from $-0.23.
Where can I find Sanara MedTech Inc.'s Q2 2026 SEC filings?
You can read the 8-K/A earnings release (0001493152-26-037112) and the 10-Q periodic report (0001493152-26-037176) directly on SEC EDGAR. The filing index links above go to sec.gov.